In a meta-analysis to assess the relationship between Ki-67/MIB-1 and cervical cancer (13 studies, 894 patients), it was found that this marker can be used as a predictor of prognosis due to its high correlation with the prognosis of the disease [28]. This evidence concerns the gene MIB1 and cervical carcinoma.